Methylphenidate Hydrochloride 75834-0324
Product NDC
75834-0324- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- April 16, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA208737
Active Ingredients
| Ingredient | Strength |
|---|---|
| Methylphenidate Hydrochloride | 5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 TABLET in 1 BOTTLE (75834-324-01)